» Articles » PMID: 33916762

Beneficial Role of Exercise in the Modulation of Muscle Plastic Remodeling and Oxidative Stress

Overview
Date 2021 Apr 30
PMID 33916762
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Duchenne muscular dystrophy (DMD) is an X-linked recessive progressive lethal disorder caused by the lack of dystrophin, which determines myofibers mechanical instability, oxidative stress, inflammation, and susceptibility to contraction-induced injuries. Unfortunately, at present, there is no efficient therapy for DMD. Beyond several promising gene- and stem cells-based strategies under investigation, physical activity may represent a valid noninvasive therapeutic approach to slow down the progression of the pathology. However, ethical issues, the limited number of studies in humans and the lack of consistency of the investigated training interventions generate loss of consensus regarding their efficacy, leaving exercise prescription still questionable. By an accurate analysis of data about the effects of different protocol of exercise on muscles of mice, the most widely-used pre-clinical model for DMD research, we found that low intensity exercise, especially in the form of low speed treadmill running, likely represents the most suitable exercise modality associated to beneficial effects on muscle. This protocol of training reduces muscle oxidative stress, inflammation, and fibrosis process, and enhances muscle functionality, muscle regeneration, and hypertrophy. These conclusions can guide the design of appropriate studies on human, thereby providing new insights to translational therapeutic application of exercise to DMD patients.

Citing Articles

Skeletal muscle disorders as risk factors for type 2 diabetes.

Tammineni E, Manno C, Oza G, Figueroa L Mol Cell Endocrinol. 2025; 599:112466.

PMID: 39848431 PMC: 11886953. DOI: 10.1016/j.mce.2025.112466.


Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance.

Bourgeois Yoshioka C, Takenaka-Ninagawa N, Goto M, Miki M, Watanabe D, Yamamoto M Stem Cell Res Ther. 2024; 15(1):313.

PMID: 39300595 PMC: 11414159. DOI: 10.1186/s13287-024-03922-x.


Manipulation of HSP70-SOD1 Expression Modulates SH-SY5Y Differentiation and Susceptibility to Oxidative Stress-Dependent Cell Damage: Involvement in Oxotremorine-M-Mediated Neuroprotective Effects.

Scordino M, Frinchi M, Urone G, Nuzzo D, Mudo G, Di Liberto V Antioxidants (Basel). 2023; 12(3).

PMID: 36978935 PMC: 10045076. DOI: 10.3390/antiox12030687.


The new challenge of "exercise + X″ therapy for Duchenne muscular dystrophy-Individualized identification of exercise tolerance and precise implementation of exercise intervention.

Su Y, Song Y Front Physiol. 2022; 13:947749.

PMID: 35991169 PMC: 9389311. DOI: 10.3389/fphys.2022.947749.


Oxidative Stress in Skeletal Muscle.

Fano-Illic G, Fulle S Antioxidants (Basel). 2022; 11(7).

PMID: 35883790 PMC: 9311499. DOI: 10.3390/antiox11071299.


References
1.
Monici M, Aguennouz M, Mazzeo A, Messina C, Vita G . Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology. 2003; 60(6):993-7. DOI: 10.1212/01.wnl.0000049913.27181.51. View

2.
Lindsay A, Larson A, Verma M, Ervasti J, Lowe D . Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle. J Appl Physiol (1985). 2018; 126(2):363-375. PMC: 6397410. DOI: 10.1152/japplphysiol.00948.2018. View

3.
Afroze D, Kumar A . ER stress in skeletal muscle remodeling and myopathies. FEBS J. 2017; 286(2):379-398. PMC: 6002870. DOI: 10.1111/febs.14358. View

4.
Gomes E, Silva A, de Oliveira M . Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species. Oxid Med Cell Longev. 2012; 2012:756132. PMC: 3372226. DOI: 10.1155/2012/756132. View

5.
Cao S, Kaufman R . Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014; 21(3):396-413. PMC: 4076992. DOI: 10.1089/ars.2014.5851. View